BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+3.95%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$9.45B
AUM Growth
+$9.45B
(+8.2%)
Cap. Flow
+$607M
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
29.09%
Holding
237
New
15
Increased
96
Reduced
78
Closed
21
Top Buys
| 1 |
ACCD
Accolade, Inc. Common Stock
ACCD
|
$53.3M |
| 2 |
ESSA Pharma
EPIX
|
$53M |
| 3 |
Revolution Medicines
RVMD
|
$47.1M |
| 4 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$39.8M |
| 5 |
Becton Dickinson
BDX
|
$32.4M |
Top Sells
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$100M |
| 2 |
Halozyme
HALO
|
$43.1M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$38.1M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$33.3M |
| 5 |
Esperion Therapeutics
ESPR
|
$32.2M |
Sector Composition
| 1 | Healthcare | 95.93% |
| 2 | Industrials | 0.88% |
| 3 | Technology | 0.47% |
| 4 | Consumer Discretionary | 0.04% |
| 5 | Financials | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELL
101
DELISTED
PhenomeX Inc. Common Stock
CELL
| $19M | 0.2% |
379,003
+218,498
| +136% | +$11M |
|
|
VCRA
102
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $18.9M | 0.2% |
492,107
+223,936
| +84% | +$8.61M |
|
103
Legend Biotech
LEGN
$6.64B
| $17.5M | 0.19% |
603,243
+186,902
| +45% | +$5.42M |
|
104
ResMed
RMD
$39.4B
| $17.1M | 0.18% |
88,145
-10,830
| -11% | -$2.1M |
|
105
Regeneron Pharmaceuticals
REGN
$59.8B
| $16.9M | 0.18% |
35,800
+8,100
| +29% | +$3.83M |
|
106
Thermo Fisher Scientific
TMO
$183B
| $16.7M | 0.18% |
36,574
-7,881
| -18% | -$3.6M |
|
107
Q32 Bio
QTTB
$20.9M
| $16.3M | 0.17% |
1,737,122
| – | – |
|
|
AMED
108
DELISTED
Amedisys
AMED
| $16M | 0.17% |
60,487
-10,703
| -15% | -$2.83M |
|
109
Avantor
AVTR
$8.74B
| $14.8M | 0.16% |
512,216
| – | – |
|
110
Inogen
INGN
$213M
| $14.8M | 0.16% |
280,863
+101,720
| +57% | +$5.34M |
|
111
Wave Life Sciences
WVE
$1.27B
| $14.6M | 0.15% |
2,602,858
| – | – |
|
112
Outset Medical
OM
$245M
| $13.9M | 0.15% |
255,714
+66,003
| +35% | +$3.59M |
|
|
GTH
113
DELISTED
Genetron Holdings Limited ADS
GTH
| $13.6M | 0.14% |
632,087
+457,238
| +262% | +$9.81M |
|
114
CareDx
CDNA
$678M
| $13M | 0.14% |
190,371
-153,612
| -45% | -$10.5M |
|
|
XENT
115
DELISTED
Intersect ENT, Inc
XENT
| $12.9M | 0.14% |
617,968
-1,513
| -0.2% | -$31.6K |
|
116
Oscar Health
OSCR
$4.57B
| $12.2M | 0.13% |
+454,574
| New | +$12.2M |
|
117
iRhythm Technologies
IRTC
$5.67B
| $12.2M | 0.13% |
87,631
-10,971
| -11% | -$1.52M |
|
|
BNR
118
Burning Rock Biotech
BNR
$85.6M
| $11.7M | 0.12% |
432,926
+247,640
| +134% | +$6.67M |
|
119
Zai Lab
ZLAB
$3.48B
| $11.5M | 0.12% |
86,500
+53,800
| +165% | +$7.18M |
|
|
TRHC
120
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $10.5M | 0.11% |
227,178
+9,203
| +4% | +$424K |
|
121
Dentsply Sirona
XRAY
$2.77B
| $10.2M | 0.11% |
159,129
| – | – |
|
|
IMAB
122
I-MAB
IMAB
$380M
| $9.62M | 0.1% |
198,457
-4,755
| -2% | -$230K |
|
123
CVS Health
CVS
$93B
| $9.37M | 0.1% |
124,548
+3,953
| +3% | +$297K |
|
124
Pulmonx
LUNG
$67.6M
| $8.07M | 0.09% |
176,510
| – | – |
|
125
Gilead Sciences
GILD
$140B
| $7.17M | 0.08% |
111,000
+26,400
| +31% | +$1.71M |
|